Stock listing

CSL Stock Price, News, Filings & Events — Csl Limited

Selected listing: CSL · ASX · AUD · AU

This page tracks Csl Limited's CSL:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CSL:ASX. CSL:ASX is the stock-level entry point for investors researching Csl Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Csl Limited is a publicly traded company on the Australian market, with a market capitalization of approximately AUD 40.85 billion. The company is known for its focus on biotechnology and biopharmaceuticals, providing innovative products and services in the healthcare sector. As a key player in its industry, Csl Limited continues to contribute to advancements in medical treatments and therapies.

CSL:ASXAUDAUUpdated August 28, 2026
Csl Limited logo
Ticker
CSL:ASX
Asset type
Stock
Market cap
$59.90B
Sector
Health Technology
Industry
Biotechnology
Exchange
ASX
Currency
AUD

Csl Limited CSL:ASX stock context

This page tracks Csl Limited's CSL:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CSL:ASX. CSL:ASX is the stock-level entry point for investors researching Csl Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Csl Limited is a publicly traded company on the Australian market, with a market capitalization of approximately AUD 40.85 billion. The company is known for its focus on biotechnology and biopharmaceuticals, providing innovative products and services in the healthcare sector. As a key player in its industry, Csl Limited continues to contribute to advancements in medical treatments and therapies.

Latest news from Csl Limited

All Csl Limited news →

Csl Limited earnings calls

Research Csl Limited

Alternate listings